Evidence map›Paper›PMID 42742072›Full record

ArticleChemistry & biodiversity2026

Flavasperfurans A and B, Two New Asperfuran Derivatives From the Marine-Derived Fungus Aspergillus flavus.

Chun-Xiu Wang, Zheng-Biao Zou, Li-Sheng Li, Cheng-Hai Gao, Xian-Wen Yang

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chun-Xiu Wang *Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning, China.ORCID https://orcid.org/0009-0001-0628-8346
Zheng-Biao Zou *Hainan Academy of Medical Sciences, Hainan Medical University, Haikou, China.ORCID https://orcid.org/0009-0001-8824-7272
Li-Sheng LiSchool of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Cheng-Hai GaoInstitute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning, China.ORCID https://orcid.org/0000-0002-7524-8049
Xian-Wen YangHainan Academy of Medical Sciences, Hainan Medical University, Haikou, China.ORCID https://orcid.org/0000-0002-4967-0844

Funding

Hainan Medical University Science and Technology Innovation Project RZ2500002135National Natural Science Foundation of China 22177143
6 · The paper itself

Abstract

Marine microorganisms represent a prolific reservoir of chemically diverse natural products endowed with considerable therapeutic potential. In the present study, two new asperfurans (1 and 2) and 23 known compounds (3-25) were obtained from Aspergillus flavus, a marine fungus isolated from a water sample of the Western Pacific. Their structures were determined by detailed analysis of the 1D and 2D NMR, HRESIMS, and NMR calculations with DP4+ probability analysis, as well as ECD calculations. Asperfuran (3) exhibited potent inhibitory activity against renin-angiotensin system-selective lethal 3 (RSL3)-induced ferroptosis with a half maximal effective concentration (EC

Indexed as

Aspergillus flavusFuransDose-Response Relationship, DrugMolecular ConformationMolecular StructureStructure-Activity RelationshipFuransAspergillus flavusferroptosis inhibitory activityfungusmarine‐derivedsecondary metabolites

Identifiers

PMID42742072
PMCPMC13576079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.